SN
Senti Biosciences, Inc.
SNTI · NASDAQ
$0.31 -3.13% (-$0.01)
1M -17.99%
Market Cap $9.65M
P/E Ratio -
Div. Yield -
ROE 1,539.97%
Bulios Fair Price
$0.35
12.9% upside
Trenutna cena
$0.31
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SNTI trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 254.08x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Book val. growth 64.72%
Rev. growth 81.15%
FCF growth N/A
Profitability
0 /100
Weak Net margin 130,432.00%
Op. margin 148,734.00%
FCF margin 100,134.00%
Quality
0 /100
Poor ROE 1,539.97%
ROA 149.72%
Asset turnover 0.00x
Debt
27 /100
High Current ratio 0.83x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
6 /100
Unstable EPS volatility 70.29%
Profitable years 0
Beta 2.12x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SNTI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Timothy K. Lu
Employees
39
Headquarters
South San Francisco
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report